Medisan(SZ:002900) Shang Hai Zheng Quan Bao·2025-08-26 20:40Core Points - The company, Harbin Sanlian Pharmaceutical Co., Ltd., has released its 2025 semi-annual report, which includes important financial and operational information [1][15]. - The board of directors and the supervisory board have both approved the semi-annual report and related documents, confirming that the information disclosed is true, accurate, and complete [24][26]. Group 1: Board Meeting - All directors attended the board meeting that reviewed the semi-annual report [2][11]. - The meeting was held on August 25, 2025, and all 9 directors participated in the voting process [10][12]. - The board approved the proposal regarding the 2025 semi-annual report with unanimous support [13][14]. Group 2: Supervisory Board Meeting - The supervisory board meeting was also held on August 25, 2025, with all 3 supervisors present [21][22]. - The supervisory board confirmed that the procedures for preparing and reviewing the semi-annual report complied with relevant laws and regulations [24]. - The board approved the proposal regarding the use of raised funds, stating that there were no violations or misuses of the funds [26].